| REVIEW ARTICLE |
|
| Year : 2012 | Volume
: 2
| Issue : 1 | Page : 15-19 |
|
|
Continuing antiplatelet therapy throughout dental procedures: A clinical dilemma
Sheeraz Badal1, Syed Ahmed1, Rohit Shrikanthan2, Afreen Badal1
1 Department of Oral & Maxillofacial Surgery, MIDSR Dental College and Hospital, Latur, India
2 Department of Oral & Maxillofacial Surgery, Raja Rajeshwari Dental College, Bangalore, India
Correspondence Address:
Sheeraz Badal
Department of Oral & Maxillofacial Surgery, MIDSR Dental College and Hospital, Latur
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2229-5194.94186
|
|
|
Antiplatelet therapy is commonly recommended for the prevention of the thromboembolic events, including the myocardial infarction and stroke. It has reduced the mortality and morbidity of cardiovascular diseases remarkably. A considerable number of patients presenting before a dentist give a history of antiplatelet therapy. A clinical dilemma exists whether to discontinue the antiplatelet therapy or to continue during the routine and invasive dental procedures. Continuing antiplatelet therapy during surgery minimizes the risk of thromboembolic complications but theoretically increases the risk of hemorrhage. Discontinuing antiplatelet therapy may expose patients to life-threatening thromboembolic events, while presumably reducing the risk of hemorrhagic complications. Diverse opinions exist regarding the management of such patients. Some advice continuation of the antiplatelet therapy rather than inviting possible thromboembolic event, while others encourages its discontinuation. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
